3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Interventions
Cisplatin
10
apatinib
5
Surgical Procedures, Operative
4
Radiotherapy
4
Paclitaxel
4
Hyperthermic Intraperitoneal Chemotherapy
4
Hydralazine
4
Gemcitabine
4
Carboplatin
4
Valproic Acid
3
Neoadjuvant Therapy
3
Drug Therapy
3
Bevacizumab
3
taxane
2
pembrolizumab
2
cetrorelix
2
Radiotherapy, Intensity-Modulated
2
Probiotics
2
Population Groups
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Metformin
2
Laparoscopy
2
Indocyanine Green
2
Etoposide
2
Curcumin
2
CP protocol
2
Brachytherapy
2
spartalizumab
1
piperine
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Etodolac
×
Gynecologic
×
Clear all
NCT06839144
2025-07-11
OC-POP-PT
Tel-Aviv Sourasky Medical Center
Phase 2
Recruiting
60 enrolled